Cheng, Y., Han, L., Wu, L., Chen, J., Sun, H., Wen, G., Ji, Y., Zimina, A. V., Shi, J., Pan, Z., Shi, J., Wang, X., Bai, Y., Melkadze, T., Pan, Y., Min, X., Viguro, M., Li, J., Wang, Q., Zhu, J. (2025). Serplulimab versus placebo plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: Efficacy and safety from the end-of-study analysis of the international phase 3 ASTRUM-005 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8093